Brain Tumor Therapeutics Market Poised for a Significant Growth Spurt, Projected to Reach USD 5.28 Billion by 2030

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Forecast 2024-2030" report has been added to's offering.

The global landscape for Brain Tumor Therapeutics is experiencing a robust growth phase, with market size estimations indicating a rise to USD 3.03 billion in 2023, and a further growth trajectory expected to lead to USD 5.28 billion by 2030. This demonstrates an impressive compound annual growth rate (CAGR) of 8.24% during the forecast period of 2024-2030. This expansion reflects both the increasing prevalence of brain tumors and significant advancements in therapeutic interventions.

Market Dynamics and Segmentation

The Brain Tumor Therapeutics Market is segmented to provide a detailed understanding of various aspects driving growth. Current trends in the following categories are meticulously evaluated:

  • Type: Evaluating therapeutics for conditions such as Glioblastoma, Meningioma, and Metastatic Brain Tumors.

  • Therapy: Understanding the progress in Chemotherapy, Gene Therapy, and Immunotherapy among other therapeutic approaches.

  • Patient Age Group: Assessing treatment effectiveness across Adult and Pediatric patient groups.

  • Distribution Channel: Analyzing the reach of Offline Vs. Online Pharmacies in the distribution of therapeutics.

  • End-User: Insight into utilization by Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.

  • Region: Providing in-depth analysis across diverse geographies including Americas, Asia-Pacific, and Europe, Middle East & Africa.

This compelling report also incorporates a comprehensive glance at market penetration strategies, developmental insights into emerging markets, diversification tactics for product lines and geographies, as well as an in-depth competitive intelligence including market shares and strategic profiles of leaders in the industry.

Key insights regarding technology trends, regulatory landscapes, and potential growth opportunities elucidate factors that are instrumental in shaping the market. The report provides essential insights for companies looking to scale up their operations and for new entrants strategizing to enter the market.

Towards a Future Empowered by Advanced Therapeutics

In an age marked by cutting-edge medical developments, the report on the Brain Tumor Therapeutics Market offers a guide for stakeholders seeking to navigate the complexities of this vital sector. The forecast and analysis it presents are crucial in charting a course for the sustained growth and enhanced patient outcomes the industry strives towards.

For inquiries related to market dynamics, industry trends, or competitive strategies within the Brain Tumor Therapeutics realm, our contribution remains unparalleled. This analysis is an indispensable tool for anyone looking to gain a comprehensive understanding of the brain tumor treatment landscape and the opportunities awaiting therein.

Key Attributes:

Report AttributeDetails
No. of Pages199
Forecast Period2024 - 2030
Estimated Market Value (USD) in 2024$3.28 Billion
Forecasted Market Value (USD) by 2030$5.28 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal

Companies Mentioned

  • AbbVie Inc.
  • Adcendo ApS
  • AIVITA Biomedical, Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Aura Biosciences, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • CNS Pharmaceuticals, Inc.
  • Curtana Pharmaceuticals
  • Dr. Reddy’s Laboratories Ltd.
  • Eisai Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies Inc.
  • Gentech, Inc.
  • GlaxoSmithKline PLC
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co. Inc.
  • Merck KGaA
  • Novartis AG
  • Novocure GmbH
  • Pfizer Inc.
  • Qiagen N.V.
  • Sanofi S.A.
  • Siemens Healthcare GmbH
  • Y-mAbs Therapeutics, Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Brain Tumor Therapeutics Market

Contact Data